Status:
COMPLETED
Visibility of Lesion Characteristics With Phase Contrast Mammography
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
40+ years
Phase:
NA
Brief Summary
To determine if diagnostic phase contrast mammography (PCM) will provide improved image detail in assessing lesion characteristics when compared to diagnostic x-ray mammography (XM).
Detailed Description
The ability to detect lesions in mammography before they can be felt is the benefit of using this imaging modality for screening of breast cancer. Screening mammography has been proven to decrease mor...
Eligibility Criteria
Inclusion
- At least 40 years old
- Female
- Scheduled for diagnostic work-up including compression/magnification views of screening detected breast lesion
Exclusion
- \< age 40
- Male
- No screening detected findings
- Breast implants
- Any women who is pregnant or has reason to believe she is pregnant or lactating
- Women with breasts larger than the 24 x 30 cm receptor
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00467727
Start Date
April 1 2007
End Date
September 1 2008
Last Update
May 1 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carolina Center for Clinical Trials, University of North Carolina
Chapel Hill, North Carolina, United States, 27599